Rheumatoid Factor

Low Disease Activity in Rheumatoid Arthritis After Tofacitinib Discontinuation

Low Disease Activity in Rheumatoid Arthritis After Tofacitinib Discontinuation

By

Approximately 1 in 3 patients with RA who discontinued tofacitinib maintained low disease activity after 1 year.

Rheumatoid Arthritis: Risk Factors, Diagnosis, and Treatment

Rheumatoid Arthritis: Risk Factors, Diagnosis, and Treatment

This article discusses the most prevalent risk factors, as well as the clinical signs and symptoms, associated with RA.

Predicting Arthritis Progression in Patients With Arthralgia

Predicting Arthritis Progression in Patients With Arthralgia

"Within patients with clinically suspect arthralgia, anti-citrullinated protein antibody was associated with increased risks on progression to clinical arthritis."

Sign Up for Free e-Newsletters